244 related articles for article (PubMed ID: 17360473)
1. A target-selected Apc-mutant rat kindred enhances the modeling of familial human colon cancer.
Amos-Landgraf JM; Kwong LN; Kendziorski CM; Reichelderfer M; Torrealba J; Weichert J; Haag JD; Chen KS; Waller JL; Gould MN; Dove WF
Proc Natl Acad Sci U S A; 2007 Mar; 104(10):4036-41. PubMed ID: 17360473
[TBL] [Abstract][Full Text] [Related]
2. Multiple mucin depleted foci, high proliferation and low apoptotic response in the onset of colon carcinogenesis of the PIRC rat, mutated in Apc.
Femia AP; Luceri C; Soares PV; Lodovici M; Caderni G
Int J Cancer; 2015 Mar; 136(6):E488-95. PubMed ID: 25257656
[TBL] [Abstract][Full Text] [Related]
3. Apc-driven colon carcinogenesis in Pirc rat is strongly reduced by polyethylene glycol.
Femia AP; Becherucci C; Crucitta S; Caderni G
Int J Cancer; 2015 Nov; 137(9):2270-3. PubMed ID: 25912754
[TBL] [Abstract][Full Text] [Related]
4. Supplementation with phytoestrogens and insoluble fibers reduces intestinal carcinogenesis and restores ER-β expression in Apc-driven colorectal carcinogenesis.
Luceri C; Femia AP; Tortora K; D'Ambrosio M; Fabbri S; Fazi M; Caderni G
Eur J Cancer Prev; 2020 Jan; 29(1):27-35. PubMed ID: 31651566
[TBL] [Abstract][Full Text] [Related]
5. Sulindac, 3,3'-diindolylmethane and curcumin reduce carcinogenesis in the Pirc rat, an Apc-driven model of colon carcinogenesis.
Femia AP; Soares PV; Luceri C; Lodovici M; Giannini A; Caderni G
BMC Cancer; 2015 Sep; 15():611. PubMed ID: 26335331
[TBL] [Abstract][Full Text] [Related]
6. Regulation of peroxisome proliferator-activated receptor-beta/delta by the APC/beta-CATENIN pathway and nonsteroidal antiinflammatory drugs.
Foreman JE; Sorg JM; McGinnis KS; Rigas B; Williams JL; Clapper ML; Gonzalez FJ; Peters JM
Mol Carcinog; 2009 Oct; 48(10):942-52. PubMed ID: 19415698
[TBL] [Abstract][Full Text] [Related]
7. Monoallelic silencing and haploinsufficiency in early murine intestinal neoplasms.
Amos-Landgraf JM; Irving AA; Hartman C; Hunter A; Laube B; Chen X; Clipson L; Newton MA; Dove WF
Proc Natl Acad Sci U S A; 2012 Feb; 109(6):2060-5. PubMed ID: 22308460
[TBL] [Abstract][Full Text] [Related]
8. Microadenomatous lesions involving loss of Apc heterozygosity in the colon of adult Apc(Min/+) mice.
Yamada Y; Hata K; Hirose Y; Hara A; Sugie S; Kuno T; Yoshimi N; Tanaka T; Mori H
Cancer Res; 2002 Nov; 62(22):6367-70. PubMed ID: 12438216
[TBL] [Abstract][Full Text] [Related]
9. The utility of Apc-mutant rats in modeling human colon cancer.
Irving AA; Yoshimi K; Hart ML; Parker T; Clipson L; Ford MR; Kuramoto T; Dove WF; Amos-Landgraf JM
Dis Model Mech; 2014 Nov; 7(11):1215-25. PubMed ID: 25288683
[TBL] [Abstract][Full Text] [Related]
10. The cyclooxygenase-2 inhibitor celecoxib is a potent preventive and therapeutic agent in the min mouse model of adenomatous polyposis.
Jacoby RF; Seibert K; Cole CE; Kelloff G; Lubet RA
Cancer Res; 2000 Sep; 60(18):5040-4. PubMed ID: 11016626
[TBL] [Abstract][Full Text] [Related]
11. Vitamin D deficiency in the
Irving AA; Duchow EG; Plum LA; DeLuca HF
Dis Model Mech; 2018 Mar; 11(3):. PubMed ID: 29590632
[TBL] [Abstract][Full Text] [Related]
12. Optimization of Erlotinib Plus Sulindac Dosing Regimens for Intestinal Cancer Prevention in an Apc-Mutant Model of Familial Adenomatous Polyposis (FAP).
Ulusan AM; Rajendran P; Dashwood WM; Yavuz OF; Kapoor S; Gustafson TA; Savage MI; Brown PH; Sei S; Mohammed A; Vilar E; Dashwood RH
Cancer Prev Res (Phila); 2021 Mar; 14(3):325-336. PubMed ID: 33277315
[TBL] [Abstract][Full Text] [Related]
13. Acute changes in colonic PGE
Yun C; Dashwood WM; Li L; Yin T; Ulusan AM; Shatzer K; Gao S; Ruan KH; Hu M
Inflamm Res; 2020 Jan; 69(1):131-137. PubMed ID: 31797003
[TBL] [Abstract][Full Text] [Related]
14. A novel mouse model of sporadic colon cancer induced by combination of conditional Apc genes and chemical carcinogen in the absence of Cre recombinase.
Souris JS; Zhang HJ; Dougherty U; Chen NT; Waller JV; Lo LW; Hart J; Chen CT; Bissonnette M
Carcinogenesis; 2019 Nov; 40(11):1376-1386. PubMed ID: 30859181
[TBL] [Abstract][Full Text] [Related]
15. Colonic polyposis caused by mTOR-mediated chromosomal instability in Apc+/Delta716 Cdx2+/- compound mutant mice.
Aoki K; Tamai Y; Horiike S; Oshima M; Taketo MM
Nat Genet; 2003 Dec; 35(4):323-30. PubMed ID: 14625550
[TBL] [Abstract][Full Text] [Related]
16. The threshold level of adenomatous polyposis coli protein for mouse intestinal tumorigenesis.
Li Q; Ishikawa TO; Oshima M; Taketo MM
Cancer Res; 2005 Oct; 65(19):8622-7. PubMed ID: 16204028
[TBL] [Abstract][Full Text] [Related]
17. High Sensitivity to Cholic Acid-induced Colonic Tumorigenesis Makes Female PIRC Rats (F344/NTac-Apc
Luceri C; Femia AP; D'Ambrosio M; Caderni G
Anticancer Res; 2019 Sep; 39(9):4673-4679. PubMed ID: 31519566
[TBL] [Abstract][Full Text] [Related]
18. Chemoprevention of intestinal polyposis in the Apcdelta716 mouse by rofecoxib, a specific cyclooxygenase-2 inhibitor.
Oshima M; Murai N; Kargman S; Arguello M; Luk P; Kwong E; Taketo MM; Evans JF
Cancer Res; 2001 Feb; 61(4):1733-40. PubMed ID: 11245490
[TBL] [Abstract][Full Text] [Related]
19. Utility of Apc-mutant rats with a colitis-associated colon carcinogenesis model for chemoprevention studies.
Kochi T; Shimizu M; Shirakami Y; Yoshimi K; Kuramoto T; Tanaka T; Moriwaki H
Eur J Cancer Prev; 2015 May; 24(3):180-7. PubMed ID: 25222193
[TBL] [Abstract][Full Text] [Related]
20. Polyethylene glycol 8000 and colon carcinogenesis: inhibition in the F344 rat, promotion in the Min mouse.
Naigamwalla D; Chia MC; Tran TT; Medline A; Hay K; Gallinger S; Bruce WR
Cancer Res; 2000 Dec; 60(24):6856-8. PubMed ID: 11156379
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
